AngioDynamics, Inc. (NASDAQ: ANGO), which was the subject of a new stake purchase by Assenagon Asset Management S.A. in the third quarter, was the subject of a new stake purchase, as stated in the company’s most recent filing with the Securities and Exchange Commission (SEC). To acquire the company, which is a distributor of medical supplies and equipment, the institutional investor paid a total of $312,000 for purchasing 15,243 shares of stock in the business.
The holdings in the company that is owned by a variety of additional hedge funds and institutional investors have also been modified as a result of this adjustment. During the second quarter, the Texas Permanent School Fund raised the total number of shares of AngioDynamics common stock that it owned by 2.1%. Texas Permanent School Fund is now the owner of 28,029 shares of the company engaged in providing medical devices and equipment. This is a result of the fund’s purchase of an additional 580 shares during the preceding quarter. These shares are currently valued at $542,000 at the current market price. As of the end of the second quarter, U.S. Bancorp DE owned 36.2% more shares of AngioDynamics than it did at the beginning of the period. U.S. Bancorp DE now has 2,562 shares of the medical instruments supplier’s stock, worth a combined total of $50,000 thanks to the acquisition of 681 additional shares during the preceding quarter. During the second quarter, Legal & General Group Plc increased the amount of AngioDynamics stock owned by 0.9%, bringing the total amount of stock owned by the company to 100%. Legal & General Group Plc now holds 93,102 shares of the stock held by the medical instruments supplier. This is after the company made an additional purchase of 851 shares during the most recent quarter. These shares are currently trading on the market for $1,802,000. During the first three months of 2018, Brinker Capital Investments LLC increased the number of AngioDynamics shares in its portfolio by 2.3%. Brinker Capital Investments LLC now holds 4,539.539 shares of the medical instruments supplier’s stock, which has a value of $895,000. This follows the acquisition of 929 additional shares during the most recent quarter. Last but certainly not least, during the second quarter, Mutual of America Capital Management LLC brought the amount of AngioDynamics stock it owned up to 16.7%, making it one of the company’s largest stock holdings. After purchasing 934 additional shares during the most recent quarter, Mutual of America Capital Management LLC now has 6,513 shares in the medical equipment provider. This brings the company’s total number of shares to 6,513. The current market price for these shares comes to a total of $126,000. To the tune of 94.94% of the company’s shares, hedge funds and other institutional investors are the owners of those shares.
Wednesday was the first-day trading could begin on NASDAQ ANGO, and the opening price was $13.83. Over the last 52 weeks, the price of one share of AngioDynamics, Inc. has ranged from a low of $11.71 to a high of $24.87. The ratio of the current ratio to the quick ratio is 1.30, while the ratio of the current ratio to the quick ratio is 2.16. The ratio of debt to equity is 0.12. The stock’s price-to-earnings ratio is currently -16.66, and its beta value is 0.66. The current share price of the company’s stock puts its market value at $541.22 million. $13.38 is the moving average for the company over the past 50 days, and $17.59 is the moving average over the past 200 days.
Recent reports on various topics, including Angola, have been compiled by various research firms worldwide. In a report published on Friday, January 6th, Raymond James decreased their price objective for AngioDynamics from $25.00 to $22.00 while maintaining their “strong-buy” rating. The first day that information was made available by StockNews.com regarding AngioDynamics share prices was October 12th, 2013. They recommended that shareholders “hold” their shares of the company.
AngioDynamics, Inc. designs, manufactures and distributes medical, surgical, and diagnostic equipment. The treatment of cancer and surgery, as well as the management of peripheral vascular disease and vascular access, are all areas in which trained medical professionals use this equipment. This is true not only in the United States but also internationally.
Do you wish to investigate other hedge funds to determine which of those funds have ANGO investments in their portfolios? By going to HoldingsChannel.com, you can research the most recent 13F filings and insider transactions for AngioDynamics, Inc. (NASDAQ: ANGO).